GlassScriptPhysician profile
Vasili Lendel
NPI 1720104516
$86,141.48
in general payments reported to CMS, 2019-2025
32 companies · $8,772 in 2025
The $8,772 reported for 2025 was more than what 88% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25K · 2020: $3,715 · 2021: $14K · 2022: $11K · 2023: $7,708 · 2024: $17K · 2025: $8,772.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Food and Beverage: $9,623 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $7,150 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,960 · Travel and Lodging: $446.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,100.00 |
| Food and Beverage | $9,622.97 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $7,150.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,960.00 |
| Travel and Lodging | $446.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $48,814.82 | 2019-2023 | Diamondback Peripheral |
| Shockwave Medical, INC | $23,606.38 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $5,133.13 | 2019-2025 | Diamondback Peripheral, Coroflow, Amplatzer Amulet |
| Boston Scientific Corporation | $1,395.11 | 2019-2025 | Ekosonic, Farapulse, Rotapro |
| Asahi Intecc USA, INC. | $1,020.91 | 2020-2025 | Asahi Ptca Guide Wire, Asahi Peripheral Vascular Wires, Asahi Coronary Wires |
| Inari Medical, INC. | $932.46 | 2021-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abiomed | $726.22 | 2019-2024 | Impella |
| Janssen Pharmaceuticals, INC | $496.63 | 2022-2024 | Xarelto |
| Livanova USA, INC. | $405.88 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $402.63 | 2022-2025 | Camzyos, Eliquis |
| Avinger INC. | $390.43 | 2022-2023 | Pantheris |
| Penumbra, INC. | $386.35 | 2024 | Indigo System, Penumbra System |
| Astrazeneca Pharmaceuticals LP | $342.84 | 2021-2025 | Wainua, Farxiga |
| Biotronik INC. | $296.49 | 2022 | |
| Mercator Medsystems, INC. | $288.45 | 2019 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $249.14 | 2025 | Rotarexs 6 F X 135 Cm |
| W. L. Gore & Associates, INC. | $243.40 | 2022-2025 | Gore Viabahn Vbx Balloon Expandable Endo |
| Lexicon Pharmaceuticals, INC. | $153.08 | 2023-2024 | Inpefa |
| Pfizer INC. | $128.83 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $127.40 | 2022-2025 | |
| Janssen Scientific Affairs, LLC | $124.32 | 2023 | Stelara |
| Bard Peripheral Vascular, INC. | $122.31 | 2020 | |
| Novo Nordisk INC | $101.64 | 2024-2025 | Wegovy |
| Teleflex LLC | $98.03 | 2023 | Guideliner |
| Opsens INC. | $73.00 | 2019 | |
| Cordis US Corp. | $23.27 | 2024 | Mynx Control |
| Merck Sharp & Dohme LLC | $21.76 | 2021 | |
| Medtronic Vascular, INC. | $12.96 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $12.51 | 2019 | |
| Sanofi-Aventis U.S. LLC | $11.10 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vasili Lendel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.